Numbers can say how large a limb is under a defined method. They say much less about what a working day involves, how a conversation with a professional felt, or what it is like to explain a condition that others may not recognise. Qualitative research exists to describe those things. It records what participants said, in their own terms, so that researchers and services can see parts of experience a measurement misses.
This article walks through the qualitative and related studies in Chapter 6 of the Field Guide, with each study's country, sample and recruitment visible. It then explains what a theme can and cannot support.
Editorial note: this article is educational and has not been medically reviewed. It explains how research is built and read. It does not diagnose, triage, prescribe or promise an outcome, and it cannot tell any reader what to expect from a service. New, rapidly changing or worrying swelling or skin changes, or fever or feeling unwell, need appropriate NHS or urgent-care advice, and breathing difficulty, chest pain or collapse needs emergency help.
What qualitative research is for
A qualitative study asks what an experience was like and why, not how often it occurs. It usually works with small groups, recruited for the richness of what they can describe. The result is a set of themes drawn from interviews, focus groups or open survey questions. Those themes are valuable evidence about what the participants reported. They are not a count of how many people share the experience.
That distinction decides how every study below should be read. The phrase to keep in mind is the one Chapter 6 uses: reported, described, or participants said, followed by the study's place, sample and limit.
The studies, with their samples in view
United Kingdom
- Watts and Davies (Journal of Advanced Nursing, 2016), Wales. A national focus-group study with 59 participants across 8 local multiprofessional lymphoedema clinics, all clinic attendees describing access and lived experience. Participants reported diagnostic delay, fragmented awareness outside specialist services and perceived value after reaching a multiprofessional clinic. It does not estimate national waiting times or the effect of every clinic model.
- Williams, Moffatt and Franks (International Journal of Palliative Nursing, 2004), UK. A phenomenological study of 15 people with lymphoedema of mixed causes. Accounts centred on uncertainty, seeking an explanation, relationships and daily roles. The sample is small and older, so it is not current evidence about UK care.
International lipoedema studies
- Melander, Juuso and Olsson (Health Care for Women International, 2022), Sweden. Narrative interviews with 14 adult women diagnosed with lipoedema, recruited through a patient association. Participants described feeling dismissed, weight being blamed, pain and heaviness, and a need for validation and emotional support.
- Falck and colleagues (International Journal of Qualitative Studies on Health and Well-being, 2024), Sweden. Semi-structured interviews with 12 women from a selected specialist context. Accounts covered social exclusion, delayed recognition and emotional work.
- Christoffersen and Tennfjord (International Journal of Environmental Research and Public Health, 2023), Norway. A study of younger women and young adults. Participants described having their concerns minimised, and spoke of the importance of being believed, social support and belonging.
- Clarke and colleagues (Quality of Life Research, 2023), Australia. A survey with qualitative elements, mostly adult women, using self-reported stage alongside questions on physical and mental health and healthcare. It supports discussion of stigma, body image, mental health burden and barriers to care. Self-reported stage and non-UK recruitment limit how far it transfers.
Related, but not interview studies
- Blome and colleagues (European Journal of Vascular and Endovascular Surgery, 2014), Germany. Development and validation of the Patient Benefit Index for lymphoedema and lipoedema. It records what patients consider relevant, including a clear diagnosis, information about therapy, fear of worsening, symptoms and daily impact. A validated benefit tool is not evidence that a treatment works.
- Moffatt and colleagues (QJM, 2003), England. A historic service-impact study describing lymphoedema as an underestimated health problem and its demands on care. It is older and not current evidence on commissioning or pathways.
The 2021 scoping review of lipoedema as a social problem (Czerwińska and colleagues, International Journal of Environmental Research and Public Health) provides a wider frame. It maps lived impact, stigma and social participation across an international, mostly adult-women, heterogeneous literature.
What participants described about daily burden
Across these studies, reported burden extends well beyond body size. Participants described pain, heaviness, clothing and movement concerns, body image and fear of being blamed. They described the effort of explaining a condition, effects on relationships and daily roles, and in some studies social exclusion. The scoping review adds stigma and reduced social participation to the picture.
These findings support taking lived impact seriously beside any clinical measure. They also help explain why patient-reported measures cover symptoms, function and emotional effects. They cannot show cause. A person can describe pain and heaviness vividly, and the description does not identify the biology behind it.
What participants described about services
On services, the accounts overlap, with differences of place. Delayed recognition appears in the Welsh and Swedish studies. Dismissal and weight being blamed appear in the Swedish interviews, and minimisation in the Norwegian study. Watts and Davies describe participants who valued recognition, knowledge and support once they reached a multiprofessional clinic. Younger Norwegian participants spoke of belonging and being believed as important in themselves.
These are reports from selected participants about their encounters. They are useful for professionals and services thinking about how conversations go. They are not a measured rate of any experience.
Why themes do not establish more than they show
They do not establish prevalence. Fourteen, twelve or fifty-nine participants cannot tell you how common an experience is. Themes show that something happened to some people and what it was like.
They do not describe the whole system. Participants were recruited through a patient association, a specialist setting or clinics. People who never reached a specialist, left a service or are not part of a patient association are less likely to be heard. The studies come from Wales, Sweden, Norway and Australia, so they cannot be read as a map of one health system, and the Nordic and Australian studies are not UK pathway evidence.
They do not prove intent. A report of dismissal can be real and important without establishing that a system or an individual professional acted from a particular motive.
They do not predict an individual's experience. Nothing in a qualitative sample tells a reader what a particular appointment will be like or how their own condition will progress.
They age. A 2004 sample and a 2016 sample describe their own times, and services change.
The UK service context around the studies
Alongside the research sit pages with different jobs. The NHS lymphoedema and lipoedema pages offer public orientation and signposting. They do not decide local eligibility, referral, funding or waiting times. Within the source set in Book 01 there is no single comprehensive NICE clinical pathway for general lymphoedema, chronic oedema or lipoedema. NICE NG101 is specific to breast cancer, and NICE NG141 covers cellulitis and erysipelas prescribing. Local commissioning shapes the route a person meets, which is why a national page cannot promise one. The UK services context page compares these roles in full.
British Lymphology Society materials add professional and operational language and Lymphoedema Support Network adds patient information and signposting. Those materials are not systematic reviews, and the qualitative studies are not service guarantees. Each answers its own question.
How to read a theme or a quotation
- Where was the study done, and what health system does that imply?
- How many participants were there, and how were they recruited?
- What condition and what age group did the study concern?
- When were the interviews done?
- Does the paper describe what experiences were not captured?
- Is the claim phrased as what participants reported, or as what always happens?
Why these studies still matter
Qualitative work shows which outcomes matter to people and so what research should measure. Blome and colleagues' benefit tool and the lymphoedema-specific questionnaires reflect that priority. The studies also give professionals language for what a person may be carrying into an appointment, such as pain, uncertainty and the work of being believed. Read at their own scale, they strengthen a conversation without deciding it.
The glossary at /resources/glossary defines the terms used here, and the research index shows where lived-experience evidence sits among the other hubs.
What this evidence does not establish
- How many people have any of these experiences.
- That any country's or the UK's system behaves in one way.
- A personal diagnosis, referral route, funding outcome or waiting time.
- That a reader must prove a label before pain, heaviness or practical burden deserves attention.
Sources used
- Watts TE, Davies RE. Qualitative national focus group study of living with lymphoedema and accessing local multiprofessional clinics. J Adv Nurs. 2016;72(12):3147-3159. DOI.
- Williams AF, Moffatt CJ, Franks PJ. A phenomenological study of the lived experiences of people with lymphoedema. Int J Palliat Nurs. 2004;10(6):279-286. DOI.
- Melander C, Juuso P, Olsson M. Women's experiences of living with lipedema. Health Care Women Int. 2022;43(1-3):54-69. DOI.
- Falck J et al. Experiences and consequences of living with lipedema. Int J Qual Stud Health Well-being. 2024;19(1):2300152. DOI.
- Christoffersen V, Tennfjord MK. Younger women with lipedema, their experiences with healthcare providers. Int J Environ Res Public Health. 2023;20(3):1925. DOI.
- Clarke C et al. Stages of lipoedema: experiences of physical and mental health and health care. Qual Life Res. 2023;32(1):127-137. DOI.
- Blome C et al. Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool. Eur J Vasc Endovasc Surg. 2014;47(1):100-107. DOI.
- Moffatt CJ et al. Lymphoedema: an underestimated health problem. QJM. 2003;96(10):731-738. DOI.
- Czerwińska M et al. Lipoedema as a social problem: a scoping review. Int J Environ Res Public Health. 2021;18(19):10223. DOI.
- NHS: Lymphoedema and Lipoedema. UK public information. NICE: NG101 and NG141. British Lymphology Society and Lymphoedema Support Network context.
